SanaClis SRL
1.0 FTESanaClis reported total assets of 46,543 € at the end of the 2025 financial year (annual accounts filed with the NBB on 19 Jun 2026), with 1 full-time equivalent.
The score of SanaClis shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
SanaClis's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 19 Jun 2026
- Year ended 31 Dec 2024filed on 20 Jun 2025
SanaClis's financial analysis
- Solvency-63.1%sector median: 60.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of SanaClis
SanaClis's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1010.302.411
- VAT number
- BE1010302411
- Peppol
- Registered · 0208:1010302411 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 12 Jun 2024
- Registered office
- 3590 Diepenbeek
- Size
- Micro · 1.0 FTE
- Latest accounts
- 2025 · filed on 19 Jun 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
SanaClis (SRL) has been based in Diepenbeek since 2024, active in: research and experimental development on biotechnology. For 2025, it reports a net loss of 31,824 € and equity of −29,357 €; its revenue is not published. With 1.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at -63.1%, below the median of its sector (60.4%).
Companies similar to SanaClis
Companies in the same business, of comparable size and area, outside its group.
- DNAVision Research and experimental development on natural sciences and engineering Charleroi · balance sheet 27,822 €
- Base LT Research and experimental development on natural sciences and engineering Herbeumont · balance sheet 47,144 €
- TYROScreen Research and experimental development on natural sciences and engineering Herve · balance sheet 48,550 €
- Sightera Biosciences Research and experimental development on natural sciences and engineering Heist-op-den-Berg · balance sheet 63,382 €
- Plus Breeding Research and experimental development on natural sciences and engineering Lokeren · balance sheet 33,093 €
- Consulting Claudine Demeyere Research and experimental development on natural sciences and engineering Dilbeek · balance sheet 66,460 €
- Dr. Frank Chielens Algemene Geneeskunde Research and experimental development on natural sciences and engineering Ypres · balance sheet 68,508 €
- IDRO Research and experimental development on natural sciences and engineering Antwerp · balance sheet 234,400 €
Frequently asked questions about SanaClis
What is the revenue of SanaClis?
SanaClis files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of SanaClis?
In Belgium, the VAT number is the company number prefixed with BE: BE1010302411 for SanaClis, if the company is VAT-registered. Its company number (CBE) is 1010.302.411.
Where is the registered office of SanaClis?
According to the CBE register, the registered office of SanaClis is in 3590 Diepenbeek.
What is the equity of SanaClis?
At the close of the 2025 financial year, the equity of SanaClis amounts to -29,357 €, a solvency of -63.1% of total assets.
How many people work at SanaClis?
1.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages SanaClis?
The register lists 2 active mandates at SanaClis. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of SanaClis
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →